Perspective · 10 Sep 2026
Conference abstractPublished 15 Oct 2013
Hepatitis B and hepatitis C viruses’ infections among antiretroviral naive and experienced HIV co-infected adults
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Although antiretroviral drugs (ARV) have significantly reduced HIV/AIDS-related deaths, co-infection with hepatitis B (HBV) and hepatitis C (HCV) viruses have increasingly contributed to the morbidity and mortality associated with HIV infection. The aim of this study was to investigate existing trend and future threats of HBV and HCV co-infections with HIV and explore the relation of HBV markers among ARV-naive and experienced subjects co-infected with HIV in Ethiopia. A total of 500 frozen HIV-positive plasma and serum samples collected from ARV-naive (n=250) and experienced (n=250) subjects seeking voluntary counseling and testing and antiretroviral therapy services in Bethezata Health Services P.L.C and Bethel Teaching General Hospital were tested for HBsAg, anti-HBs, HBeAg, and anti-HCV. Of 500 subjects tested, 15 (3%), 58 (11.6%), 3 (0.6%), 18 (3.6%), 3 (0.6%), and 1 (0.2%) were positive for HBsAg, anti-HBs, HBeAg, anti-HCV, HBsAg and HBeAg, and HBsAg and anti-HBs respectively. No patient was tested positive for both HBeAg and anti-HBs, and 442 (88.4%) subjects were non-immune to HBV. Of 250 ARV-naive subjects tested, 8 (3.2%), 33 (13.2%), 2 (0.8%), 10 (4%), 2 (0.8%), and 1 (0.4%) were positive for HBsAg, anti-HBs, HBeAg, anti-HCV, HBsAg and HBeAg, and HBsAg and anti-HBs respectively. Of 250 ARV-experienced subjects tested, 7 (2.8%), 25 (10%), 1 (0.4%), 8 (3.2%), 1 (0.4%), and 0 (0%) were positive for HBsAg, Anti-HBs, HBeAg, anti- HCV, HBsAg and HBeAg, and HBsAg and anti-HBs respectively. HBV and HCV infections were not significantly different between persons who were or who were not on ARV which suggests that the two groups have equal chances to be infected with these two infectious diseases despite disease progression.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Tsegahun Manyzewal”
- BylineArticles whose byline prints “Zufan Sisay”
- BylineArticles whose byline prints “Sibhatu Biadgilign”
- BylineArticles whose byline prints “Woldaregay Erku Abegaz”
